Literature DB >> 8683765

Percutaneous vacuum vesicolithotomy under direct vision: a new technique.

J G Van Savage1, A E Khoury, G A McLorie, B M Churchill.   

Abstract

PURPOSE: The number of vesical calculi is increasing as the number of patients with intestinocystoplasty increases. We describe our technique for easily removing vesical calculi in children via an atraumatic percutaneous endoscopic approach.
MATERIALS AND METHODS: The procedure involves percutaneous suprapubic puncture and direct visualization of the calculi via cystoscopy through the urethra or via a second suprapubic puncture when the bladder neck is closed. The stones are vacuumed up 1 at a time with suction tubing through the suprapubic working sheath in a controlled manner with no urethral trauma. Ten patients 3 to 16 years old (mean age 8) with vesicolithiasis underwent percutaneous vacuum vesicolithotomy under direct vision in 1993 to 1995.
RESULTS: Two to 12 bladder calculi were extracted (mean 7). All calculi less than 1 cm. were removed by this procedure. All bladder calculi between 1 and 1.5 cm. were also removed but they required simultaneous electrohydraulic lithotripsy. There were no complications at a mean 1-year followup. Mean hospitalization was less than 24 hours (range 0 to 3 days).
CONCLUSIONS: Percutaneous vacuum vesicolithotomy is highly successful, easy to perform and safe for extracting vesical calculi. Since the procedure is done through a percutaneous sheath, it is particularly suited to the individual with an absent, small caliber, sensitive or surgically reconstructed urethra.

Entities:  

Mesh:

Year:  1996        PMID: 8683765     DOI: 10.1097/00005392-199608001-00038

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  1 in total

1.  Combined use of percutaneous and transurethral instruments in the preadolescent children with intravesical pathologies.

Authors:  Yusuf Kibar; Hasan C Irkilata; Hidayet Coban; Ibrahim Yildirim; Murat Dayanç
Journal:  Int Urol Nephrol       Date:  2007-03-01       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.